Pharmacy News EU

STOCK MARKETING INC PRESENTS : (OTCBB: NPHC) Nutra Pharma Corp., (NASDAQ: GNBT) Generex Biotechnology Corp., (OTCBB: VKNG) Viking Systems, Inc., (OTCBB: ISCO) International Stem Cell Corp., (OTCBB: AJGH) American Jianye Greentech Holdings Inc., (OTCBB: NWCI) Newcardio, Inc.www.StockMarketingInc.comFor More Information email us!! Steve@StockMarketingInc.com
(OTCBB: NPHC – Nutra Pharma Corp.)LATEST NEWS!!Nutra Pharma Receives Patent for Novel Antiviral Treatment [...]

NATICK, Mass., July 29 /PRNewswire-FirstCall/ Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration approval of two spinal cord stimulation (SCS) leads for use with its Precision Plus? Spinal Cord Stimulator System, the world's first rechargeable SCS device for the management of chronic pain of the trunk and/or limbs. The Linear? [...]

MARLBOROUGH, Mass.(BUSINESS WIRE) Advanced Cell Technology, Inc. (ACT?; OTCBB:ACTC) announced today that it has submitted documentation and a complete response to substantively address the issues raised by the US Food and Drug Administration (FDA) in [...]

ROCKLAND, Mass., July 28 /PRNewswire/ EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for Cladribine Tablets as a therapy for relapsing forms of multiple sclerosis (MS).The application also has been granted a Priority [...]

www.HeroStocks.comGiving Average Traders Super Powers One Alert At A Time!These stocks made it to our watch list… time to put them on yours!NPHC.OB / XCHO.OB / GNBT / VKNG.OB / ISCO
NPHC.OB – Nutra Pharma Corp.Super News!Nutra Pharma Receives Patent for Novel Antiviral Treatment Using Modified Cobra VenomNutra Pharma Has Been Issued a Patent by the [...]

TEWKSBURY, Mass.(BUSINESS WIRE) Cambridge Heart, Inc. (OTCBB: CAMH), today announced that Ali Haghighi-Mood, President and Chief Executive Officer, is scheduled to present at the upcoming 2010 Southern California Investor Conference sponsored by Global Hunter Securities. [...]

CAMBRIDGE, Mass., July 27, 2010 (GLOBE NEWSWIRE) Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today provided an update regarding a lawsuit that Sanofi-Aventis U.S. LLC filed in the United States District Court for the District of Columbia against the U.S. Food and Drug Administration (FDA), [...]

DALLAS, July 27 The American Heart Association issued the following news release:To improve emergency care for heart attack patients, new research suggests that expanding percutaneous coronary intervention (PCI) capacity at hospitals is less effective than using emergency medical services (EMS) to transport patients directly to existing PCI centers. Outcomes are most improved and costs [...]

CAMBRIDGE, Mass. Biotechnology company Momenta Pharmaceuticals Inc. said Tuesday a federal court placed no restrictions on the sale of a generic version of Sanofi-Aventis SA’s Lovenox, an injected drug that prevents blood clots.Momenta, which is based in Cambridge, Mass., said Sanofi has filed a lawsuit that asked, among other things, for a temporary restraining [...]

CAMBRIDGE, Mass.(BUSINESS WIRE) Genzyme Corp. (NASDAQ: GENZ) today said it welcomed the Centers for Medicare and Medicaid Services (CMS) decision not to include oral medications without IV equivalents in Medicare’s End Stage Renal Disease (ESRD) [...]